good sense migraine formula
Generic: acetaminophen, aspirin, caffeine
Labeler: l. perrigo companyDrug Facts
Product Profile
Brand Name
good sense migraine formula
Generic Name
acetaminophen, aspirin, caffeine
Labeler
l. perrigo company
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0113-0374
Product ID
0113-0374_4acb9fbd-30d3-42fa-9e71-410ef5d6f413
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA075794
Listing Expiration
2026-12-31
Marketing Start
2002-04-17
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01130374
Hyphenated Format
0113-0374
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
good sense migraine formula (source: ndc)
Generic Name
acetaminophen, aspirin, caffeine (source: ndc)
Application Number
ANDA075794 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (0113-0374-62) / 24 TABLET, FILM COATED in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (0113-0374-78) / 100 TABLET, FILM COATED in 1 BOTTLE
Packages (2)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4acb9fbd-30d3-42fa-9e71-410ef5d6f413", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["f052512b-e55a-4369-8c9c-453c9a5686a3"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["L. Perrigo Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0113-0374-62) / 24 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0113-0374-62", "marketing_start_date": "20020417"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0113-0374-78) / 100 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0113-0374-78", "marketing_start_date": "20020417"}], "brand_name": "good sense migraine formula", "product_id": "0113-0374_4acb9fbd-30d3-42fa-9e71-410ef5d6f413", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "0113-0374", "generic_name": "Acetaminophen, Aspirin, Caffeine", "labeler_name": "L. Perrigo Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "good sense migraine formula", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA075794", "marketing_category": "ANDA", "marketing_start_date": "20020417", "listing_expiration_date": "20261231"}